TrialThe journal of allergy and clinical immunology. In practice2022

Benralizumab Completely Depletes Gastrointestinal Tissue Eosinophils and Improves Symptoms in Eosinophilic Gastrointestinal Disease.

Fei Li Kuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.